Skip to content
Neurolentech website
Precision Medicine for Neurodevelopmental Disorders
ABOUT
PIPELINE
NEWS
TEAM
CAREER
CONTACT
News
Press release
TESS Foundation invests in Neurolentech’s approach for SLC13A5